Business · 14/11/2003
FDA Releases Revised Guidance on Q3B(R) Impurities in New Drug Products
The FDA has made available a revised guidance on impurities in new drug products, clarifying and updating previous guidance, and aligning with more recent ICH guidelines, under the International Conference on Harmonisation
Original source language: Federal Register — Food and Drug AdministrationOpen original release →